SARAH KANE: Open Payments
NPI 1558875534 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 18 payments from 10 companies in 2025. Trend: 2023 $597 · 2024 $849 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $83 |
| Almatica Pharma LLC | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: VRAYLAR, LOREEV XR, CAPLYTA, FANAPT, Auvelity, REXULTI, Jornay PM, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
